Lung cancer

6 currently open clinical trials

Anti-PD-1 monoclonal antibody pembrolizumab versus placebo for patients with lung cancer

EORTC PEARLS

Durvalumab in patients with advanced lung cancer and poor general state of health

SAKK 19/17

Single arm phase II trial evaluating the activity of Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC

ETOP ALERT

A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment in advanced malignant pleural mesothelioma

ETOP BEAT-meso

Adjuvant immunotherapy for limited-stage small cell lung cancer

ACHILES

Immunotherapy and radiotherapy in stage III non-small cell lung cancer

SAKK 16/18

All cancer types